Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company’s Access Family of Immunoassay Systems.

TSH Resources Bhd has executed a share buyback, acquiring 740,000 shares at a consistent price of MYR 1.250 per share, amounting to a total consideration of MYR 930,827.50.